New research in mice suggests that reprogramming the liver with mRNA could strengthen vaccination responses and cancer ...

A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after COVID-19 mRNA vaccination, ...

Pfizer said on Tuesday the next few years will be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering immune responses and sustaining protection, according to an analysis ...

The entire vaccine ecosystem is under threat, prompted less by data than a seeming desire to upend a system that has worked well for the American population for decades.

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

The 2024–2025 formulations of COVID-19 vaccines had an effectiveness rate of 76% at preventing emergency or urgent care ...

NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

A week of fast-moving developments has left some with questions about access to the COVID-19 vaccine. While experts and officials say the new federal guidance surrounding COVID vaccine authorization ...

Eli Lilly’s retatrutide exceeds expectations in Phase III, capping off a sparkling 2025 for the obesity titan; an internal ...

A Harvard study found that the children of women who contracted COVID-19 while pregnant may be at an increased risk for autism and other diagnoses, raising new concerns about the CDC’s decision to ...